Key Takeaways:
Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH) raised its full-year 2026 outlook after first-quarter results beat analyst estimates, supported by improved reimbursement rates and higher patient volumes. Shares rose more than 5% in premarket trading.
“Q1 reflects the strength and resiliency of our business model with an impressive start to 2026,” Jeff Shaner, Chief Executive Officer at Aveanna, said. “Our first quarter results saw revenue and adjusted EBITDA increase 15.9% and 25.2%, respectively, when compared to the prior year period.”
The home healthcare provider reported adjusted earnings of $0.18 per share on revenue of $647.9 million, a 15.9% increase from the same period last year. Analysts expected earnings of $0.13 per share on revenue of $613.19 million. Net income was $41.7 million, up sharply from $5.2 million a year earlier.
Following the strong performance, Aveanna raised its full-year 2026 financial outlook. The company now expects revenue between $2.56 billion and $2.58 billion, up from a previous forecast of $2.54 billion to $2.56 billion. The adjusted EBITDA forecast was lifted to a range of $328 million to $332 million.
The results show a continuation of positive momentum for the company, which has now surpassed consensus EPS estimates for four consecutive quarters. Revenue growth was recorded across all three of Aveanna’s operating divisions, with the Private Duty Services (PDS) segment contributing an additional $75.7 million compared to the prior-year quarter.
The updated guidance suggests management is confident that improved operating conditions will persist. Investors will look for further details on segment margins and patient volume trends during the company's upcoming earnings call.
This article is for informational purposes only and does not constitute investment advice.
